Caris Life Sciences, Inc. (CAI)
32.00
+0.29
(+0.91%)
USD |
NASDAQ |
Oct 23, 16:00
32.00
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Price : 32.00 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 31.74 | 32.16 | 30.95 | 32.00 | 2.322M |
| Oct 22, 2026 | 32.00 | 32.61 | 30.33 | 31.71 | 2.423M |
| Oct 21, 2026 | 31.11 | 32.75 | 30.92 | 32.35 | 2.234M |
| Oct 20, 2026 | 30.71 | 31.56 | 30.10 | 31.11 | 3.537M |
| Oct 19, 2026 | 31.26 | 31.99 | 30.62 | 30.71 | 2.103M |
| Oct 16, 2026 | 31.76 | 32.40 | 30.16 | 30.56 | 2.731M |
| Oct 15, 2026 | 29.50 | 32.15 | 28.80 | 31.76 | 3.554M |
| Oct 14, 2026 | 29.23 | 31.53 | 29.02 | 30.26 | 4.347M |
| Oct 13, 2026 | 29.48 | 29.78 | 28.66 | 29.53 | 3.524M |
| Oct 12, 2026 | 29.94 | 30.13 | 28.49 | 29.69 | 4.998M |
| Oct 09, 2026 | 27.82 | 29.84 | 27.67 | 29.70 | 5.034M |
| Oct 08, 2026 | 26.75 | 27.62 | 25.87 | 27.50 | 3.862M |
| Oct 07, 2026 | 27.10 | 27.56 | 26.06 | 27.10 | 4.882M |
| Oct 06, 2026 | 30.69 | 32.56 | 27.28 | 27.46 | 4.748M |
| Oct 05, 2026 | 28.30 | 30.46 | 28.30 | 30.39 | 4.959M |
| Oct 02, 2026 | 28.72 | 28.97 | 28.07 | 28.30 | 3.205M |
| Oct 01, 2026 | 30.60 | 30.96 | 28.29 | 28.35 | 4.407M |
| Sep 30, 2026 | 31.40 | 32.04 | 30.60 | 30.63 | 2.930M |
| Sep 29, 2026 | 31.64 | 32.32 | 30.82 | 31.55 | 3.714M |
| Sep 28, 2026 | 31.73 | 32.09 | 30.88 | 31.75 | 3.939M |
| Sep 25, 2026 | 32.65 | 32.77 | 31.58 | 31.98 | 2.919M |
| Sep 24, 2026 | 31.34 | 32.40 | 30.91 | 32.27 | 5.982M |
| Sep 23, 2026 | 31.12 | 32.89 | 31.10 | 31.65 | 4.360M |
| Sep 22, 2026 | 31.55 | 32.36 | 31.33 | 31.47 | 5.960M |
| Sep 21, 2026 | 30.23 | 30.71 | 29.97 | 30.65 | 6.147M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CareDx, Inc. | 69.21 |
| Natera, Inc. | 403.95 |
| Myriad Genetics, Inc. | 5.82 |
| BioRestorative Therapies, Inc. | 1.62 |
| Exagen, Inc. | 7.27 |
Price Related Metrics
| PE Ratio | 85.95 |
| PS Ratio | 9.136 |
| Price to Book Value | 15.28 |
| Price to Free Cash Flow | 77.77 |
| Earnings Yield | 1.16% |
| Market Cap | 9.043B |
| Operating PE Ratio | 58.99 |
| Normalized PE Ratio | 71.96 |